ONCO
Onconetix, Inc.Company with tickers: ONCO
CIK
1782107
CUSIP
68237Q203
Shares Outstanding
11,464,572
Website
https://www.onconetix.com
Investor Relations
https://ir.onconetix.com/
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $21,457 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $23,112 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Gross Profit | $-1,655 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Expenses | $10,224,146 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | — | ||||
| Operating Income | $-10,225,801 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-4,214,875 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-6.71 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-6.71 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Geography (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Switzerland | $58,465 | $2,437,159 | $796,590 |
| United Kingdom | — | $23,842 | $18,781 |
| United States | — | $63,115 | — |
| Non European Union | — | $23,842 | — |
| European Union | — | $2,437,159 | — |
By Product & Service (USD)
| Component | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| License | — | — | $600,000 |
| Other Revenues | — | — | $587,882 |
| Product Sales | — | $249,028 | $225,835 |
| Development Service | — | $2,275,088 | $1,654 |
| development Services | $58,465 | — | — |